Products
Online Inquiry
Acipimox
Cat. No.:
OB0225WX-2220
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Acipimox is a nicotinic acid analog and niacin derivative that functions at the molecular level as a hypolipidemic agent.
Synonym:
Olbemox; K-9321; 51037-30-0; 5-Carboxy-2-methylpyrazine 1-oxide; Olbemox; 5-methylpyrazine-2-carboxylic acid 4-oxide; 5-Methylpyrazinecarboxylic acid 4-oxide; 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid; MFCD00865757; 5-Methyl-2-pyrazinecarboxylic acid 4-oxide; 5-Carboxy-2-methylpyrazine1-oxide
CAS No.:
51037-30-0
Compound CID:
5310993
Formula:
C6H6N2O3
Formula Weight:
154.12
Specification
Relative Density:
1.44 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Acipimox is utilized in lipid metabolism research as a nicotinic acid derivative to investigate the inhibition of lipolysis and its impact on reducing plasma free fatty acid and triglyceride levels.
Library Information
Target:
Others
Pathways:
Others
Plate Number:
AOCL-29
Plate Location:
d5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 324.42 mM
Water Max Solubility:
15.4 mg/mL; 100 mM
